Eastgate Biotech Corporation (CE) (ETBI) Fundamentals

Description
EastGate Biotech Corp. is a biotech company concentrating on altering the delivery ways for well-known drugs, currently administered only by injections, to non-invasive (oral or sublingual) routes. We are developing a technology platform for enhanced drug delivery designed to improve compliance and increase health benefits to fit todays health-conscious lifestyles. At the present time our technology focuses on the delivery of insulin via a liquid insulin mouth solution based on a proprietary/Trade Secret composition for the treatment of Type 2 diabetes patients and Alzheimers disease. We believe that our technology may also be applicable to the delivery of other active pharmaceutical ingredients. We may also develop other novel formulations of pharmaceutical and natural products. The company has identified several biologically active existing molecules that address unmet needs of patients, especially those with ever-growing chronic conditions.
Share Info
StatusActive
Market Cap$ 2,538,858
Shares Authorized3,000,000,000
Shares Outstanding1,057,857,377
Shares Outstanding Date06/20/2022
Shareholder Count170
Shareholder Count Date08/15/2020
Float-
Float Date-
Short Interest92,501
Short Interest Date05/31/2022
Reporting Info
Reporting StatusAlternative Reporting Standard
BankruptNo
ShellNo
Audit StatusYes
Auditor-
Auditor Address-
Auditor Website-
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselCarmel, Milazzo & Feil LLP
Legal Counsel Address55 West 39th Street
18th Floor
New York, New York 10018
USA
Legal Counsel Websitehttp://cmdllp.com
Fiscal Year End12/31
ADR Ratio-
Transfer AgentVStock Transfer LLC
Transfer Agent Address18 Lafayette Place
Woodmere, NY 11598
USA
Depository Websitehttp://www.vstocktransfer.com
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:ETBI
OTC Market TierExpert Market
Security TypeCommon Stock
CIK Number0001099574
Address2203-65 Harbour Square
Toronto, Ontario M5J 2L4
CountryCanada
Phone(647) 692-0652
Fax #-
Websitehttp://www.eastgatebiotech.com/
SIC Code / Description6799 / Investors, misc
Key ExecutivesAccountant - Erwin Vahlsing, Jr.
Accountant - Olga Naumova
CEO - Anna Gluskin
President - Rose C. Perri
COO - Bill Abajian
COO - William Abajian
Number of Employees-
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year1999


Your Recent History
USOTC
ETBI
Eastgate B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.